Silence Therapeutics (SLN) Shares Issued (2020 - 2025)
Silence Therapeutics' Shares Issued history spans 6 years, with the latest figure at $1000.0 for Q2 2025.
- On a quarterly basis, Shares Issued fell 99.92% to $1000.0 in Q2 2025 year-over-year; TTM through Dec 2025 was $15000.0, a 99.99% decrease, with the full-year FY2025 number at $15000.0, down 99.99% from a year prior.
- Shares Issued hit $1000.0 in Q2 2025 for Silence Therapeutics, down from $14000.0 in the prior quarter.
- Over the last five years, Shares Issued for SLN hit a ceiling of $133.0 million in Q1 2024 and a floor of -$98000.0 in Q4 2024.
- Historically, Shares Issued has averaged $16.7 million across 5 years, with a median of $904000.2 in 2021.
- Biggest five-year swings in Shares Issued: surged 193727.9% in 2022 and later tumbled 100.79% in 2024.
- Tracing SLN's Shares Issued over 5 years: stood at $1348.0 in 2021, then skyrocketed by 10515.44% to $143097.3 in 2022, then skyrocketed by 8541.39% to $12.4 million in 2023, then tumbled by 100.79% to -$98000.0 in 2024, then surged by 101.02% to $1000.0 in 2025.
- Business Quant data shows Shares Issued for SLN at $1000.0 in Q2 2025, $14000.0 in Q1 2025, and -$98000.0 in Q4 2024.